Evidence map›Paper›PMID 30567728›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2019

Transthyretin Stimulates Tumor Growth through Regulation of Tumor, Immune, and Endothelial Cells.

Chih-Chun Lee, Xinchun Ding, Ting Zhao, Lingyan Wu, Susan Perkins, Hong Du, Cong Yan

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 2 pooled it
1.1field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 2 syntheses or guidelines pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Evaluation of Genotoxicity and Toxicity ofMolecules (Basel, Switzerland) · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. The role of transthyretin in cell biology: impact on human pathophysiology.Cellular and molecular life sciences : CMLS · 2021
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Chih-Chun LeeDepartment of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN 46202; and.
Xinchun DingDepartment of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN 46202; and.
Ting ZhaoDepartment of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN 46202; and.
Lingyan WuDepartment of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN 46202; and.ORCID 0000-0002-6378-9745
Susan PerkinsDepartment of Biostatistics, Indiana University School of Medicine, Indianapolis, IN 46202.
Hong DuDepartment of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN 46202; and coyan@iupui.edu hongdu@iupui.edu.ORCID 0000-0001-6652-4702
Cong YanDepartment of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN 46202; and coyan@iupui.edu hongdu@iupui.edu.
Indiana University School of Medicine

Funding

Metabolic Regulation ofPD-L1 in CD11c+ CellsR01CA225108 · NCI · INDIANA UNIVERSITY INDIANAPOLIS · PI DU, HONG, YAN, CONG · 2019 to 2023
$2.7M
Pathophysiology of PPARgamma in the lungR01HL087001 · NHLBI · INDIANA UNIVERSITY INDIANAPOLIS · PI DU, HONG · 2008 to 2012
$1.9M
Stat3 Downstream Genes as Lung Adenocarcinoma BiomarkersR01CA138759 · NCI · INDIANA UNIVERSITY INDIANAPOLIS · PI YAN, CONG · 2010 to 2014
$1.8M
Inflammation and Immunosuppression in Lung CancerR01CA152099 · NCI · INDIANA UNIVERSITY INDIANAPOLIS · PI YAN, CONG · 2011 to 2015
$1.5M
NCI NIH HHS R01 CA138759NCI NIH HHS R01 CA152099NCI NIH HHS R01 CA225108NHLBI NIH HHS R01 HL087001
6 · The paper itself

Abstract

Early detection of lung cancer offers an important opportunity to decrease mortality while it is still treatable and curable. Thirteen secretory proteins that are Stat3 downstream gene products were identified as a panel of biomarkers for lung cancer detection in human sera. This panel of biomarkers potentially differentiates different types of lung cancer for classification. Among them, the transthyretin (TTR) concentration was highly increased in human serum of lung cancer patients. TTR concentration was also induced in the serum, bronchoalveolar lavage fluid, alveolar type II epithelial cells, and alveolar myeloid cells of the CCSP-rtTA/(tetO)

Indexed as

Gene Expression Regulation, NeoplasticAlveolar Epithelial CellsAnimalsBiomarkers, TumorBronchoalveolar Lavage FluidCell MovementCell ProliferationDisease Models, AnimalEndothelial CellsHumansLung NeoplasmsMelanoma, ExperimentalMiceMice, Inbred C57BLMice, TransgenicMyeloid CellsBiomarkers, TumorPrealbuminRecombinant ProteinsSTAT3 protein, humanSTAT3 Transcription Factor

Identifiers

PMID30567728
PMCPMC6344285
OpenAlexW2905429904

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.